Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20?24, 2024, organized by the International Society for Antiviral Research

Thumbnail Image

Files

Meeting_Report.pdf (1.77 MB)

Links to Files

https://www.sciencedirect.com/science/article/pii/S0166354224002481

Permanent Link

https://doi.org/10.1016/j.antiviral.2024.106037
 http://hdl.handle.net/11603/37875

Collections

UMBC Chemistry & Biochemistry Department
UMBC Faculty Collection

Author/Creator

Author/Creator ORCID

https://orcid.org/0000-0002-0154-3459

Date

2024-12-01

Type of Work

journal articles
Text

Department

Program

Citation of Original Publication

Welch, Stephen R., John P. Bilello, Kara Carter, Leen Delang, Larissa Dirr, David Durantel, Joy Y. Feng, et al. "Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20?24, 2024, Organized by the International Society for Antiviral Research." Antiviral Research 232 (December 1, 2024): 106037. https://doi.org/10.1016/j.antiviral.2024.106037.

Rights

This work was written as part of one of the author's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.
Public Domain

Subjects

Abstract

The 37th International Conference on Antiviral Research (ICAR) was held in Gold Coast, Australia, May 20–24, 2024. ICAR 2024 featured over 75 presentations along with two poster sessions and special events, including those specifically tailored for trainees and early-career scientists. The meeting served as a platform for the exchange of cutting-edge research, with presentations and discussions covering novel antiviral compounds, vaccine development, clinical trials, and therapeutic advancements. A comprehensive array of topics in antiviral science was covered, from the latest breakthroughs in antiviral drug development to innovative strategies for combating emerging viral threats. The keynote presentations provided fascinating insight into two diverse areas fundamental to medical countermeasure development and use, including virus emergence at the human-animal interface and practical considerations for bringing antivirals to the clinic. Additional sessions addressed a variety of timely post-pandemic topics, such as the hunt for broad spectrum antivirals, combination therapy, pandemic preparedness, application of in silico tools and AI in drug discovery, the virosphere, and more. Here, we summarize all the presentations and special sessions of ICAR 2024 and introduce the 38th ICAR, which will be held in Las Vegas, USA, March 17–21, 2025.